Compare Abeona Therapeutics Inc (ABEO) vs United Parcel Service Inc (UPS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs United Parcel Service Inc — how do they compare? Abeona Therapeutics Inc trades at $6.76 (market cap $373.32M), while United Parcel Service Inc trades at $110.06 (market cap $95.17B). The key difference: United Parcel Service Inc is far larger — about 254.9× Abeona Therapeutics Inc's market cap, and United Parcel Service Inc pays a 5.86% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | UPS | |
|---|---|---|
Market Cap | $373.32M | $95.17B |
Sector | Health | Industrials |
52-Week High | $7.23 | $120.00 |
52-Week Low | $4.17 | $82.58 |
Enterprise Value | $228.22M | $118.03B |
Volume | — | 2,288,643 |
Dividend Yield | — | 5.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
UPS trades at $111.96, up 1.15% with a bullish technical signal. Recent earnings beat expectations (Q1 2026 EPS of $1.07 vs. $1.02 expected), though revenue declined to $88.66B in 2025. The company invests in healthcare logistics and AI to boost efficiency. Valuation ratios appear reasonable with P/E of 17.8 and P/S of 1.06. Analyst consensus is mixed with 42% buy ratings and a $111 price target.
Outlook: UPS faces revenue pressure but maintains solid profitability (ROE 33.41%). Strategic investments in temperature-controlled facilities and AI could drive growth. Risks include competitive threats and economic sensitivity. The stock offers stability with dividend income, but upside may be limited near the consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
